Accelerating Science: How to cure the incurable with cell and gene therapy

Sengenics



Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics.

Using the Pan-Autoimmune Protein Array 1.0, Sengenics can screen autoantibodies...

The i-Ome ®  Discovery Protein Array enables you to profile patient sa...

The OncoRex p53 Cancer Array provides a biologically relevant screening tool since a...

Using the CTA Protein Array, Sengenics can quantify autoantibodies against more...

Using the i-Ome ®  Discovery Protein Array, Sengenics can profile agai...

Browse All Sengenics Products (see all)

Browse Products by Field